Search Results
Bispecific antibodies in multiple myeloma: their current role and the future
What should myeloma patients know about bispecific antibodies?
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
Bispecific Antibodies in Multiple Myeloma | Dana-Farber Cancer Institute
Bispecific Monoclonal Antibodies and CAR T-Cell Therapy in Multiple Myeloma, Omar Nadeem, MD
Antibody-drug conjugates in multiple myeloma: current status and future considerations
Symposium | Looking to the future of bispecific antibodies in MM
The future of CAR T-cells and bispecific antibodies to treat myeloma
The Future of Bispecific Antibodies - Blood Cancer OncTalk 2023
A Promising Future for Treating Multiple Myeloma with Bispecific Antibodies
Current and Future Treatment of Multiple Myeloma
Bispecific Antibodies in Multiple Myeloma
